Copley Acquisition Corp shareholders approved an extension of the deadline to complete a business combination from November 2, 2026, to November 2, 2027. In connection with the extension, the company issued a $2.4 million promissory note to its sponsor to fund monthly deposits of $200,000 into the trust account. Additionally, shareholders redeemed approximately $137.1 million worth of shares, leaving roughly $46.2 million in the trust account.
Copley Acquisition Corp announced the adjournment of its Extraordinary General Meeting from October 29, 2026, to November 2, 2026. The meeting was adjourned to allow shareholders more time to consider and approve an extension of the company's deadline to consummate an initial business combination by up to 12 months.
Copley Acquisition Deal Termination with Ignite Proteomics, LLC
Copley Acquisition Corp and Ignite Proteomics, LLC have mutually agreed to terminate their previously announced Business Combination Agreement, effective October 9, 2026. As a result, all ancillary agreements including support and lock-up agreements are also terminated, and Copley intends to continue seeking an alternative business combination before its November 2, 2026 deadline.
Copley Acquisition $900K Debt Financing with Copley Acquisition Sponsors LLC
Copley Acquisition Corp issued an amended and restated convertible promissory note to its sponsor, increasing the maximum principal amount from $450,000 to $900,000. The non-interest bearing note is intended for working capital and can be converted into units at $7.00 per unit upon a business combination or liquidation.
Value
$900K
Counterparty
Copley Acquisition Sponsors LLC
Term
through the earlier of business combination or liquidation